% | $
Quotes you view appear here for quick access.

La Jolla Pharmaceutical Co. Message Board

  • neverabogey neverabogey Oct 19, 2004 3:49 PM Flag

    not good for us, someone is on our back

    15:32 ET Immunomedics reports updated clinical results on Lupus (IMMU) 3.44 +0.26: Co reports that all fourteen patients enrolled in its Phase II study of epratuzumab in systemic lupus erythematosus showed symptomatic improvement 24 hours after the last treatment.

26.33-0.59(-2.19%)Sep 23 4:00 PMEDT